To read this content please select one of the options below:

Patient centricity: lip service or genuine commitment? A qualitative examination of the pharmaceutical industry

Lea Prevel Katsanis (Department of Marketing, John Molson School of Business, Concordia University, Montreal, Canada)
Dennis Pitta (Department of Marketing, Merrick School of Business, University of Baltimore, Baltimore, Maryland, USA)
Anne Morinville (Department of Marketing, John Molson School of Business, Concordia University, Montreal, Canada)

International Journal of Pharmaceutical and Healthcare Marketing

ISSN: 1750-6123

Article publication date: 31 December 2020

Issue publication date: 22 March 2021

342

Abstract

Purpose

The purpose of this study is two-fold: first, to identify the degree of adoption of patient centricity in the pharmaceutical industry and second, to understand how the industry operationalizes this strategy. It is an important shift in the industry because of its central focus on the patient.

Design/methodology/approach

A content analysis was used based on publicly available documentation that includes industry publications, company and brand websites and clinical trial publications to identify the frequency of words used to describe patient centricity.

Findings

The key finding of this study is that the leading pharmaceutical firms overwhelmingly use patient support/access programs as the primary method of implementing patient centric strategies.

Research limitations/implications

Future research is needed to identify what impact these strategies have on patients; and whether or not these strategies have an impact on lowering drug prices and improved clinical outcomes for patients.

Practical implications

Future research is needed to identify what impact these strategies have on patients; and whether or not these strategies have an impact on lowering drug prices and improved clinical outcomes for patients. Limitations include the reliance on publicly available documentation.

Social implications

Pharmaceutical firms need to be aware that their publically available profile suggests a one-dimensional approach to patient centricity and this may influence the way patients, physicians and policymakers view their attitudes toward patients. This study is the first to systematically examine the activities of leading pharmaceutical firms with respect to the adoption and implementation of patient-centric strategies in a comprehensive fashion.

Originality/value

This study is the first to systematically examine the activities of leading pharmaceutical firms with respect to the adoption and implementation of patient-centric strategies in a comprehensive fashion.

Keywords

Citation

Katsanis, L.P., Pitta, D. and Morinville, A. (2021), "Patient centricity: lip service or genuine commitment? A qualitative examination of the pharmaceutical industry", International Journal of Pharmaceutical and Healthcare Marketing, Vol. 15 No. 1, pp. 106-133. https://doi.org/10.1108/IJPHM-02-2020-0010

Publisher

:

Emerald Publishing Limited

Copyright © 2020, Emerald Publishing Limited

Related articles